Gregers G. Hermann

3.9k total citations
59 papers, 2.0k citations indexed

About

Gregers G. Hermann is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Gregers G. Hermann has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 14 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Gregers G. Hermann's work include Bladder and Urothelial Cancer Treatments (26 papers), Urinary and Genital Oncology Studies (17 papers) and Renal cell carcinoma treatment (8 papers). Gregers G. Hermann is often cited by papers focused on Bladder and Urothelial Cancer Treatments (26 papers), Urinary and Genital Oncology Studies (17 papers) and Renal cell carcinoma treatment (8 papers). Gregers G. Hermann collaborates with scholars based in Denmark, United States and Sweden. Gregers G. Hermann's co-authors include Thomas Horn, Kenneth Steven, K. Steven, Karin Mogensen, J. Nørdling, Erik Kristensen, Peter Sommer, Kurt K. Nielsen, Poul Geertsen and Steen Carlsson and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Gregers G. Hermann

58 papers receiving 1.9k citations

Peers

Gregers G. Hermann
Beat Roth Switzerland
Andrew T. Lenis United States
K. Eugene United States
Gregers G. Hermann
Citations per year, relative to Gregers G. Hermann Gregers G. Hermann (= 1×) peers Sarel Halachmi

Countries citing papers authored by Gregers G. Hermann

Since Specialization
Citations

This map shows the geographic impact of Gregers G. Hermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregers G. Hermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregers G. Hermann more than expected).

Fields of papers citing papers by Gregers G. Hermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregers G. Hermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregers G. Hermann. The network helps show where Gregers G. Hermann may publish in the future.

Co-authorship network of co-authors of Gregers G. Hermann

This figure shows the co-authorship network connecting the top 25 collaborators of Gregers G. Hermann. A scholar is included among the top collaborators of Gregers G. Hermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregers G. Hermann. Gregers G. Hermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Schie, Iwan W., Gregers G. Hermann, Karin Mogensen, et al.. (2021). Morpho-molecular signal correlation between optical coherence tomography and Raman spectroscopy for superior image interpretation and clinical diagnosis. Scientific Reports. 11(1). 9951–9951. 12 indexed citations
5.
Ataman, Ç‪ağlar, Gregers G. Hermann, Karin Mogensen, et al.. (2019). Morpho-molecular ex vivo detection and grading of non-muscle-invasive bladder cancer using forward imaging probe based multimodal optical coherence tomography and Raman spectroscopy. The Analyst. 145(4). 1445–1456. 25 indexed citations
6.
Zare, Reza, Magnus Grabe, Gregers G. Hermann, & Per‐Uno Malmström. (2018). Can routine outpatient follow-up of patients with bladder cancer be improved? A multicenter prospective observational assessment of blue light flexible cystoscopy and fulguration. Research and Reports in Urology. Volume 10. 151–157. 6 indexed citations
7.
Mogensen, Karin, et al.. (2016). Hospitalization for transurethral bladder resection reduces quality of life in Danish patients with non-muscle-invasive bladder tumour. Scandinavian Journal of Urology. 50(3). 170–174. 18 indexed citations
8.
Westh, Henrik, et al.. (2013). A microbiological evaluation of level of disinfection for flexible cystoscopes protected by disposable endosheaths. BMC Urology. 13(1). 46–46. 13 indexed citations
9.
Vásquez, Juan Luis, et al.. (2013). Exploration of two methods for quantitative Mitomycin C measurement in tumor tissue in vitro and in vivo. Biological Procedures Online. 15(1). 12–12. 1 indexed citations
10.
Reinert, Thomas, Michael Borre, Anders Christiansen, et al.. (2012). Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation. PLoS ONE. 7(10). e46297–e46297. 93 indexed citations
11.
Vásquez, Juan Luis, Julie Gehl, & Gregers G. Hermann. (2012). Electroporation enhances mitomycin C cytotoxicity on T24 bladder cancer cell line: A potential improvement of intravesical chemotherapy in bladder cancer. Bioelectrochemistry. 88. 127–133. 18 indexed citations
13.
Mansilla, Francisco, Niels Fristrup, Karin Birkenkamp‐Demtröder, et al.. (2011). Low ANXA10 expression is associated with disease aggressiveness in bladder cancer. British Journal of Cancer. 105(9). 1379–1387. 41 indexed citations
14.
Hermann, Gregers G., Thomas Horn, & Kenneth Steven. (1998). THE INFLUENCE OF THE LEVEL OF LAMINA PROPRIA INVASION AND THE PREVALENCE OF P53 NUCLEAR ACCUMULATION ON SURVIVAL IN STAGE T1 TRANSITIONAL CELL BLADDER CANCER. The Journal of Urology. 159(1). 91–94. 106 indexed citations
15.
Horn, Thomas, et al.. (1993). Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.. PubMed. 53(5). 1162–6. 143 indexed citations
16.
Hermann, Gregers G., Poul Geertsen, Hans von der Maase, et al.. (1992). Recombinant interleukin-2 and lymphokine-activated killer cell treatment of advanced bladder cancer: clinical results and immunological effects.. PubMed. 52(3). 726–33. 22 indexed citations
17.
Hermann, Gregers G., Kresten Rubeck Petersen, Kenneth Steven, & Jesper Zeuthen. (1990). Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: Decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cells. Journal of Clinical Immunology. 10(6). 311–320. 17 indexed citations
18.
Sommer, Peter, Kurt K. Nielsen, Erik Kristensen, et al.. (1990). Voiding Patterns in Men Evaluated by a Questionnaire Survey. British Journal of Urology. 65(2). 155–160. 62 indexed citations
19.
Sommer, Peter, Kurt K. Nielsen, Erik Kristensen, et al.. (1990). Voiding Patterns and Prevalence of Incontinence in Women.: A Questionnaire Survey. British Journal of Urology. 66(1). 12–15. 146 indexed citations
20.
Bubeník, J, et al.. (1988). Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinoma. Immunology Letters. 18(2). 115–118. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026